Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GLUE

Monte Rosa Therapeutics, Inc.

CIK 0001826457 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$14.30
↓ 0.48 (-3.25%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Options

Key stats

Market Cap
$1.22B
P/E Ratio
-7.57
EPS
Not covered
Dividend Yield
Not covered
52W Position
47%
Beta
0.97

Valuation multiples

Fwd P/E
10.86
PEG
Not covered
P/B
2.50
P/S
42.47
EV/Revenue
39.33
ROE
-33.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 47%
$4.30$25.77

Latest Financials

2025-12-31 FY
Revenue
$123.67M
Net Income
-$38.63M
Total Assets
$448.66M
Free Cash Flow
-$27.50M

Recent news